Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: High-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs, G3) are aggressive cancers of the digestive system with poor prognosis and survival. Platinum-based chemotherapy (cisplatin/carboplatin +etoposide) is considered standard first-line palliative treatment. Etoposide is frequently administered intravenously, however oral etoposide is often used as an alternative. Concerns for oral etoposide include decreased bioavailability, inter- & intrapatient variability and patient compliance.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Ali A
Authors: Ali A, Grönberg M, Hjortland G, Grønbæk H, Ladekarl M,
Keywords: chemotherapy, Neuroendocrine Neoplasms, Intravenous, Oral, survival,
#1455 Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3)
Introduction: Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) are aggressive, highly proliferating tumors. Therapeutic response to current chemotherapy regimens is usually short-lasting.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Ali A, Grönberg M, Federspiel B, Hjortland G, Ladekarl M,
Keywords: Neuroendocrine Carcinoma, mutation, p53, overall survival,
#46 Neuroendocrine markers are expressed in human mammary glands
Introduction: Regulatory peptides have previously been detected in epithelial cells of human mammary glands. As these peptides are produced by scattered neuroendocrine cells in the epithelium of other tissues the aim of this study was to investigate whether the mammary glands express molecular markers for neuroendocrine cells.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Grönberg M, Amini R, Stridsberg M, Janson E, Saras J,
Keywords: Breast; Chromogranin; Ghrelin; Obestatin; Secretogranin; Vesicular monoamine transporter,